Skip to content

UNITED HEALTH PRODUCTS, INC.: 10-Q filed 2015-08-19

What UNITED HEALTH PRODUCTS, INC. reported in its quarterly report filed 2015-08-19 (fiscal Q2 2015): 26 published measures, 64 facts as tagged in accession 0001477932-15-005472.

This filing

Form
10-Q (quarterly report)
Filed
2015-08-19
Fiscal period
fiscal Q2 2015
Accession
0001477932-15-005472 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All UNITED HEALTH PRODUCTS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-06-30444,500USD
At 2014-12-3141,015USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-06-30-658,374USD
At 2014-12-31-1,609,510USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-06-301,180USD
At 2014-12-318,272USD
At 2014-06-301,534USD
At 2013-12-311,855USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2015-01-01 to 2015-06-30-406,526USD181
2014-01-01 to 2014-06-30-175,818USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2015-04-01 to 2015-06-3021,966USD91
2015-01-01 to 2015-06-3031,858USD181
2014-01-01 to 2014-06-30146,773USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2015-01-01 to 2015-06-30401,734USD181
2014-01-01 to 2014-06-30175,497USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2015-01-01 to 2015-06-30-2,300USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-06-30-11,391,210USD
At 2014-12-31-9,668,287USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-01-01 to 2015-06-301,347,224USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-147,946USD91
2015-01-01 to 2015-06-30-1,719,444USD181
2014-04-01 to 2014-06-30-198,505USD91
2014-01-01 to 2014-06-30-347,691USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-06-30442,200USD
At 2014-12-3141,015USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2015-04-01 to 2015-06-303,479USD91
2015-01-01 to 2015-06-303,479USD181
2014-04-01 to 2014-06-3017,175USD91
2014-01-01 to 2014-06-3034,351USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-06-301,102,874USD
At 2014-12-311,650,525USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-157,467USD91
2015-01-01 to 2015-06-30-1,733,813USD181
2014-04-01 to 2014-06-30-198,505USD91
2014-01-01 to 2014-06-30-451,277USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2015-06-30440,586USD
At 2014-12-3131,873USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2015-04-01 to 2015-06-309,521USD91
2015-01-01 to 2015-06-3014,369USD181
2014-01-01 to 2014-06-30103,586USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-06-30140,844,181shares
At 2014-12-31108,198,000shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2015-06-3010,585,492USD
At 2014-12-317,609,329USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2015-06-302,300USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-151,425USD91
2015-01-01 to 2015-06-30-1,722,923USD181
2014-04-01 to 2014-06-30-215,680USD91
2014-01-01 to 2014-06-30-382,042USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-157,467USD91
2015-01-01 to 2015-06-30-1,733,813USD181
2014-04-01 to 2014-06-30-173,505USD91
2014-01-01 to 2014-06-30-401,277USD181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2014-04-01 to 2014-06-30-25,000USD91
2014-01-01 to 2014-06-30-50,000USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-3,479USD91
2015-01-01 to 2015-06-30-3,479USD181
2014-04-01 to 2014-06-30-17,175USD91
2014-01-01 to 2014-06-30-34,351USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-06-30-5,027USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-30-408,713USD181
2014-01-01 to 2014-06-3020,622USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-30226,969USD181
2014-01-01 to 2014-06-3052,803USD181

Inspect the source

Entity
UNITED HEALTH PRODUCTS, INC. / CIK 0001096938
Captured
2026-09-20T05:22:35.874Z
SEC response SHA-256
ac6cf9d703c0adca8f17a2c8b6ab295df7496239afbd8b7d9c595d23b1e2267e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001096938.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))